GENE ONLINE|News &
Opinion
Blog

PROTAC
Trials & Approvals DACDegrader-Antibody ConjugatePROTACADCAntibody-Drug ConjugateBTK DegraderAntibody Neodegrader Conjugate
Targeted Cancer Therapy Breakthrough: Degrader-Antibody Conjugates (DACs) Advance to Clinical Trials
2024-02-19
R&D DACDegrader-Antibody ConjugatePROTAC
Degrader-Antibody Conjugates (DACs): Targeted Protein Degradation for Therapeutics
2024-02-19
Funding Targeted Protein Degradation
Plexium Bags $102 Million for Targeted Protein Degraders
2022-02-24
Special Targeted Protein Degrader
Expanding Deals and Investments Underscore Burgeoning Market of Targeted Protein Degradation
2021-10-07
R&D Breast Cancer
Pfizer Inks Second Collaboration with Arvinas, Makes Billion-Dollar Investment on a Novel Agent for Breast Cancer Therapy
2021-07-26
New Frontiers in Therapeutics
2020-07-25Partner
LATEST
Neuro, Pain, and Cancer Top the List at JPM 2025 Healthcare Conference
2025-01-17
ZYN Nicotine Pouches Receive FDA Marketing Authorization
2025-01-17
Virginia’s Insurance Marketplace Extends Open Enrollment Deadline: A Detailed Report
2025-01-16
2025 Starts with a Jolt: Layoffs Hit the Life Sciences Industry Ahead of JPM
2025-01-16
Eli Lilly Steals the Spotlight at JPM 2025 with $2.5 Billion Power Move Acquisition
2025-01-16
Pre-JPM 2025: The Quiet Deals You May Have Missed Before the Big Show
2025-01-16
JPM 2025’s Billion Dollar Deal – GSK Bids Big in GI Cancer
2025-01-15
READ MORE
EVENT
2025-02-05
Precision Medicine World Conference 2025
Santa Clara, California
2025-02-19
Healthcare Conference Taipei 2025
Taipei, Taiwan
2025-03-17
BIO-Europe Spring 2025
Milan, Italy
2025-04-02
Asia Cell and Gene Therapy Innovation Summit 2025
Shanghai, China
2025-04-21
World Vaccine Congress 2025
Washington, U.S.A
2025-04-25
AACR Annual Meeting 2025
Chicago, U.S.A
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2025 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top